SLYG - ETF AI Analysis
Top Page
SPDR S&P 600 Small Cap Growth ETF (SLYG)
Rating:68Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year, showing solid momentum in its small-cap growth strategy.
Leading Holdings Performing Well
Several of the top positions, especially in health care and technology, have shown strong price performance, helping drive the fund’s returns.
Low Expense Ratio
The fund’s relatively low fee means more of the investment returns stay in investors’ pockets compared with many actively managed alternatives.
Negative Factors
High U.S. Concentration
With almost all assets in U.S. companies, the ETF offers little geographic diversification and is heavily tied to the U.S. economy.
Small-Cap Volatility
Because it focuses on smaller growth companies, the fund can be more sensitive to market swings and economic slowdowns than large-cap funds.
Sector Tilts Toward Cyclical Areas
Significant exposure to sectors like industrials, technology, and consumer cyclical means the ETF may be more affected by changes in business cycles and investor risk appetite.
SLYG vs. SPDR S&P 500 ETF (SPY)
AUM4.85B
RegionNorth America
Expense Ratio0.15%
Beta0.94
IssuerSPDR
Inception DateSep 25, 2000
Dividend Yield0.72%
Asset ClassEquity
Index TrackedS&P Small Cap 600 Growth
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume133,886
30 Day Avg. Volume117,956
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
140.07Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering348
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SLYG Summary
SLYG is the SPDR S&P 600 Small Cap Growth ETF, which follows the S&P SmallCap 600 Growth Index. It invests in many smaller U.S. companies that are trying to grow quickly, across areas like technology, health care, and industrials. Some of its holdings include ViaSat and Brinker International. An investor might choose SLYG to add growth potential and diversification from large, well-known stocks, since it spreads money across many smaller firms. However, small-cap growth stocks can be more volatile, so the ETF’s price can move up and down more sharply than the overall market.
How much will it cost me?The SPDR S&P 600 Small Cap Growth ETF (SLYG) has an expense ratio of 0.15%, meaning you’ll pay $1.50 per year for every $1,000 invested. This is lower than average for ETFs because it is passively managed, tracking the S&P SmallCap 600 Growth Index rather than relying on active stock picking.
What would affect this ETF?SLYG could benefit from a strong U.S. economy, as its focus on small-cap growth companies in sectors like Industrials and Technology aligns with innovation and infrastructure trends. However, rising interest rates or economic slowdowns may negatively impact small-cap stocks, which are often more sensitive to borrowing costs and market volatility. Regulatory changes or sector-specific challenges in areas like Health Care or Financials could also influence the ETF's performance.
SLYG Top 10 Holdings
SLYG’s story is all about fast-moving U.S. small caps, with tech and health care names setting the tone. FormFactor and ViaSat are among the rising tech players, helping to pull the fund higher, while Protagonist Therapeutics and TG Therapeutics add some punch from the biotech side with generally steady-to-strong momentum. On the flip side, Esco Technologies and StoneX have been lagging lately, acting like a bit of sand in the gears. Overall, the ETF leans into innovative, domestically focused growth companies rather than big, steady blue chips.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Formfactor | 1.37% | $66.55M | $11.04B | 263.89% | 68 Neutral | |
| ViaSat | 1.15% | $55.44M | $10.25B | 137.71% | 56 Neutral | |
| Protagonist Therapeutics | 1.08% | $52.48M | $8.97B | 111.84% | 68 Neutral | |
| Ryman | 0.98% | $47.47M | $8.25B | 36.44% | 66 Neutral | |
| TG Therapeutics | 0.91% | $44.10M | $7.99B | 42.99% | 65 Neutral | |
| StoneX Group | 0.87% | $42.22M | $7.96B | 51.58% | 58 Neutral | |
| Alkermes | 0.85% | $41.11M | $6.99B | 34.57% | 80 Outperform | |
| Federal Signal | 0.85% | $40.96M | $7.21B | -0.08% | 76 Outperform | |
| Zurn Water Solutions | 0.84% | $40.85M | $7.94B | 1.33% | 79 Outperform | |
| Esco Technologies | 0.84% | $40.63M | $8.32B | 28.22% | 70 Neutral |
SLYG Technical Analysis
Negative
―
Price Trends
112.93
Negative
112.72
Negative
106.50
Positive
Market Momentum
-1.21
Negative
37.84
Neutral
70.28
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SLYG, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 108.87, equal to the 50-day MA of 112.93, and equal to the 200-day MA of 106.50, indicating a neutral trend. The MACD of -1.21 indicates Negative momentum. The RSI at 37.84 is Neutral, neither overbought nor oversold. The STOCH value of 70.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SLYG.
SLYG Peer Comparison
Comparison Results
Performance Comparison
SLYG
SPDR S&P 600 Small Cap Growth ETF
107.82
14.87
16.00%
FNDA
Schwab Fundamental US Small Co. Index ETF
―
―
―
IJT
iShares S&P Small-Cap 600 Growth ETF
―
―
―
VTWG
Vanguard Russell 2000 Growth ETF
―
―
―
FYC
First Trust Small Cap Growth AlphaDEX Fund
―
―
―
VIOG
Vanguard S&P Small-Cap 600 Growth ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents